Medication Monitor

Generic Name (Trade Name—Company)
May 1, 2011


(Coumadin—Bristol-Myers Squibb)
Recall of 1,000-count bottle for superpotency

A lot of 1,000-count bottles of Coumadin 5 mg tablets (9H49374A) have been voluntarily recalled because the tablets may be a higher potency than expected, FDA said. Testing of a single tablet from a returned bottle of Coumadin showed that it was more potent than it should have been.